Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

“Nano-Free” Sunscreen Claim Spurs Environmental Group Complaint

This article was originally published in The Tan Sheet

Executive Summary

Friends of the Earth claims that materials supplier Antaria misleads its customers and consumers by billing the ZinClear-IM sunscreen ingredient as “nano-free” when third-party testing shows it contains “clusters” of nanoparticles. The issue of defining nanotechnology continues to be debated internationally.

You may also be interested in...



In Nanotech Metrics, Safety Should Trump Size, Experts Say

Presenters at the FDLI annual conference say evaluations of novel health care and consumer products based on nanotechnology should focus on safety and efficacy more than particle size. The Project on Emerging Nanotechnologies is updating its product inventory to include nanomaterial safety data.

In Nanotech Metrics, Safety Should Trump Size, Experts Say

Presenters at the FDLI annual conference say evaluations of novel health care and consumer products based on nanotechnology should focus on safety and efficacy more than particle size. The Project on Emerging Nanotechnologies is updating its product inventory to include nanomaterial safety data.

Nanotech Is “More Than Just Tiny,” Requires FDA Regulation – Lawsuit

Environmental advocacy groups ask FDA to regulate the use of nano-sized particles, particularly in sunscreens and other personal care products, according to a lawsuit seeking an agency response to their 2006 citizen petition that made the same request.

Related Content

Topics

UsernamePublicRestriction

Register

PS105898

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel